Total Knee Replacement With Tourniquet or Aquamantys

Overview

The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the Aquamantys® bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no Aquamantys®). By doing this study, investigators hope to learn if short duration tourniquet knee replacement with the Aquamantys® bipolar sealer is more effective than standard of care (tourniquet used throughout the case and no Aquamantys®). The purpose of this study is to compare quadriceps muscle strength, pain, opioid consumption and patient function during the first three months after short-stay total knee replacement between patients treated with short-duration tourniquet knee replacement with the Aquamantys® bipolar sealer versus those treated with the standard of care (tourniquet used throughout the case and no Aquamantys®).

Full Title of Study: “Comparison to Short-duration Tourniquet Total Knee Arthroplasty (TKA) With the Aquamantys® Bipolar Sealer and the Standard of Care in the Setting of Outpatient TKA: A Randomized, Double-blinded Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Outcomes Assessor)
  • Study Primary Completion Date: February 7, 2023

Interventions

  • Device: Aquamantys
    • The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
  • Device: Tourniquet
    • Standard of care for reducing bleeding during the total knee arthroplasty

Arms, Groups and Cohorts

  • Experimental: Aquamantys
    • The Aquamantys bipolar sealer is a device used during surgery to help reduce bleeding in the joint. The system uses radiofrequency energy and sterile saline (salt water) to close small blood vessels in the knee to help reduce bleeding.
  • Active Comparator: Standard of Care: Tourniquet
    • Standard of care for reducing bleeding during the total knee arthroplasty

Clinical Trial Outcome Measures

Primary Measures

  • Isometric quadriceps strength
    • Time Frame: 2 weeks
    • The participant will sit in a seated position and a stabilizing strap will be placed around the bottom of the participant’s shank and attached to a hand-held dynamometer. The participant will be asked to slowly kick the foot as hard as they can into the dynamometer pad (muscle testing hardware), and force will be measured. Increased measured force indicates greater quadriceps strength.

Secondary Measures

  • Pain (VAS)
    • Time Frame: Preoperative, 2 weeks, 6 weeks, 12 weeks
    • Pain will be measured using the visual analog scale (VAS), which assess pain levels on a scale from 0-10. Lower numbers indicate less pain while higher numbers indicate more pain.
  • Knee Osteoarthritis (KOOS,JR)
    • Time Frame: Preoperative, 2 weeks, 6 weeks, 12 weeks
    • Knee injury Osteoarthritis Outcome Score, Joint Replacement (KOOS,JR) patient-reported outcome score. The KOOS, JR contains 7 items from the original KOOS survey. Items are coded from 0 to 4, none to extreme respectively. KOOS, JR is scored by summing the raw response (range 0-28) and then converting it to an interval score. The interval score ranges from 0 to 100 where 0 represents total knee disability and 100 represents perfect knee health.
  • Emotional Health (VR-12 MCS)
    • Time Frame: Preoperative
    • The Veterans Rand-12 Mental Component Score will be used to quantify the impact of the participants emotional health on their daily activities. The VR-12 consists of 12 questions, is scored from 0-100 with lower scores indicating that emotional health has a more dramatic impact on the participant’s daily life.
  • Knee function questionnaire
    • Time Frame: Preoperative, 2 weeks, 6 weeks, 12 weeks
    • The knee function questionnaire is a study-specific questionnaire to assess knee problems that may affect everyday life. It consists of three questions: one about walking support, one about going up stairs and one about coming down stairs. Responses are categorical, and will be used to compare the proportion of patients in each group that can walk without a walker or cane, or navigate stairs without the use of upper body support. The knee function questionnaire is not a graded scale, but will be used to assess the proportion of each group that self-reports the ability to perform these 3 tasks at each of the study time points.
  • Sit to stand test
    • Time Frame: 6 weeks, 12 weeks
    • This is a timed test used to measure mobility and function. Participants are positioned in a standard 16″ office chair with their arms at their sides and back located against the back of the chair. Participants are instructed to stand and sit as quickly as possible 5 times. The test is timed using a stopwatch and the timer is stopped when the individual achieves a standing position on the 5th trial. Shorter times indicate better mobility and function.
  • Opioid Use
    • Time Frame: Preoperative, 2 weeks, 6 weeks, 12 weeks
    • Opioid use will be assessed with a single question with a binary response (either yes the participant is taking opioid medications or no they are not).
  • Isometric quadriceps strength
    • Time Frame: 6 weeks and 12 weeks
    • Strength will be assessed at multiple time points during the study. The participant will sit in a seated position and a stabilizing strap will be placed around the bottom of the participant’s shank and attached to a hand-held dynamometer. The participant will be asked to slowly kick the foot as hard as they can into the dynamometer pad (muscle testing hardware) placed on the anterior aspect of the participant’s distal tibia. One practice trial followed by 3 actual trials will be performed. The participant will receive a 30-second rest in between each trial and a 1-minute rest in between legs for each test to prevent fatigue. Increased measured force indicates greater quadriceps strength.

Participating in This Clinical Trial

Inclusion Criteria

  • primary total knee arthroplasty Exclusion Criteria:

  • repeat knee replacement (revision arthroplasty) – bilateral knee replacements on the same day – partial knee replacements – health or social limitations that do not allow for the participant to be discharged to home on the same day or day after surgery.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Stephen Duncan
  • Collaborator
    • Medtronic
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Stephen Duncan, Associate Professor – University of Kentucky
  • Overall Official(s)
    • Stephen Duncan, MD, Principal Investigator, University of Kentucky

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.